Wei C, Su L, Liu L, Zhou D, et al. Combined oral PI3Kdelta inhibitor linperlisib and HDAC inhibitor chidamide in relapsed/refractory peripheral T-cell lymphoma: a multicenter phase 1 trial. Leuk Lymphoma 2026 Mar 3:1-9. doi: 10.1080/10428194.2026.2631800.
PMID: 41773975